Tarhini, A., Tan, A. C., Naqa, I. E., Lee, S., Stephen Hodi, F., Butterfield, L., … Kirkwood, J. (2021). 87 Enhanced immunogenicity within the tumor microenvironment and the circulation of high-risk melanoma patients with unknown primary compared to those whose primary melanoma is known. In Regular and Young Investigator Award Abstracts (pp. A95–A95). BMJ Publishing Group Ltd. https://doi.org/10.1136/jitc-2021-sitc2021.087

Tarhini, Ahmad, Aik Choon Tan, Issam El Naqa, Sandra Lee, F. Stephen Hodi, Lisa Butterfield, William LaFramboise, et al. “87 Enhanced immunogenicity within the tumor microenvironment and the circulation of high-risk melanoma patients with unknown primary compared to those whose primary melanoma is known.” In Regular and Young Investigator Award Abstracts, A95–A95. BMJ Publishing Group Ltd, 2021. https://doi.org/10.1136/jitc-2021-sitc2021.087.

Tarhini A, Tan AC, Naqa IE, Lee S, Stephen Hodi F, Butterfield L, et al. 87 Enhanced immunogenicity within the tumor microenvironment and the circulation of high-risk melanoma patients with unknown primary compared to those whose primary melanoma is known. In: Regular and Young Investigator Award Abstracts. BMJ Publishing Group Ltd; 2021. p. A95–A95.

Tarhini, Ahmad, et al. “87 Enhanced immunogenicity within the tumor microenvironment and the circulation of high-risk melanoma patients with unknown primary compared to those whose primary melanoma is known.” Regular and Young Investigator Award Abstracts, BMJ Publishing Group Ltd, 2021, pp. A95–A95. Crossref, doi:10.1136/jitc-2021-sitc2021.087.

Tarhini A, Tan AC, Naqa IE, Lee S, Stephen Hodi F, Butterfield L, LaFramboise W, Storkus W, Conejo-Garcia J, Hwu P, Streicher H, Sondak V, Kirkwood J. 87 Enhanced immunogenicity within the tumor microenvironment and the circulation of high-risk melanoma patients with unknown primary compared to those whose primary melanoma is known. Regular and Young Investigator Award Abstracts. BMJ Publishing Group Ltd; 2021. p. A95–A95.